http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2299728-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea19e0731220210359e8acf5a8e0aa41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a87d56708762d536c595ca08d2652a4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc62f10858b021914ffb97c64501eac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bdf6640dca29114cf679a8db119bd82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adfef131c9c70a2454a8f8cbf6e48c8e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-45
filingDate 2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcafd96e49f4be3196fcfbdcac1e8108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0632fa23e110bf4415f9a6f8a69b44eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfe88c3182758e1afb7e4565b15a60ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e6526ecaf2966d53b3c7f0e9483210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf2ce4edd3b1aa3fe7bfb84686a3dfb
publicationDate 2007-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2299728-C1
titleOfInvention Method for prophylaxis of chronic pyelonephritis exacerbation in pregnant females
abstract FIELD: medicine, obstetrics, nephrology. n SUBSTANCE: invention relates to a method for prophylaxis of chronic pyelonephritis exacerbation in pregnant women. Method involves carrying out pharmacotherapy in combination using position therapy and physiotreatment beginning from the second half of pregnancy. The preparation "Yantar'-antitoks" is prescribed additionally in the dose 0.5 g, 3 times per a day after eating for 2 weeks. Then the schedule of treatment is 0.5 g per a day for 3 weeks. Then courses in dosing the preparation are alternated up to fetus delivery. Method provides reducing toxic effect of bacterial flora, shows the cytoprotective effect, eliminates energetic misbalance in kidney tissue, effects on inflammation process and improves secretory and disintoxication function of kidneys. n EFFECT: improved method of prophylaxis. n 2 ex
priorityDate 2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715

Total number of triples: 26.